156 related articles for article (PubMed ID: 31212130)
1. Regulator of G protein signaling 20 promotes proliferation and migration in bladder cancer via NF-κB signaling.
Li G; Wang M; Ren L; Li H; Liu Q; Ouyang Y; He L; Li F
Biomed Pharmacother; 2019 Sep; 117():109112. PubMed ID: 31212130
[TBL] [Abstract][Full Text] [Related]
2. TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.
Tan ST; Liu SY; Wu B
Cancer Res Treat; 2016 Oct; 48(4):1302-1312. PubMed ID: 26987391
[TBL] [Abstract][Full Text] [Related]
3. NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.
Xiong M; Chen L; Zhou L; Ding Y; Kazobinka G; Chen Z; Hou T
Theranostics; 2019; 9(24):7156-7167. PubMed ID: 31695759
[No Abstract] [Full Text] [Related]
4. ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes.
Li X; Shang D; Shen H; Song J; Hao G; Tian Y
Biomed Pharmacother; 2020 Jun; 126():110066. PubMed ID: 32172065
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway: involvement of the p21WAF1 expression.
Lee EJ; Lee SJ; Kim S; Cho SC; Choi YH; Kim WJ; Moon SK
Cell Signal; 2013 Oct; 25(10):2025-38. PubMed ID: 23770289
[TBL] [Abstract][Full Text] [Related]
6. NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo.
Cui X; Shen D; Kong C; Zhang Z; Zeng Y; Lin X; Liu X
Sci Rep; 2017 Jan; 7():40723. PubMed ID: 28139689
[TBL] [Abstract][Full Text] [Related]
7. Rab23 is overexpressed in human bladder cancer and promotes cancer cell proliferation and invasion.
Jiang Y; Han Y; Sun C; Han C; Han N; Zhi W; Qiao Q
Tumour Biol; 2016 Jun; 37(6):8131-8. PubMed ID: 26715272
[TBL] [Abstract][Full Text] [Related]
8. Ursolic acid induces apoptosis via Akt/NF-κB signaling suppression in T24 human bladder cancer cells.
Gai L; Cai N; Wang L; Xu X; Kong X
Mol Med Rep; 2013 May; 7(5):1673-7. PubMed ID: 23483134
[TBL] [Abstract][Full Text] [Related]
9. SETD6 regulates NF-κB signaling in urothelial cell survival: Implications for bladder cancer.
Mukherjee N; Cardenas E; Bedolla R; Ghosh R
Oncotarget; 2017 Feb; 8(9):15114-15125. PubMed ID: 28122346
[TBL] [Abstract][Full Text] [Related]
10. Rab11 Functions as an Oncoprotein via Nuclear Factor kappa B (NF-κB) Signaling Pathway in Human Bladder Carcinoma.
Gong X; Liu J; Zhang X; Dong F; Liu Y; Wang P
Med Sci Monit; 2018 Jul; 24():5093-5101. PubMed ID: 30032159
[TBL] [Abstract][Full Text] [Related]
11. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
[TBL] [Abstract][Full Text] [Related]
12. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
Inoue S; Ide H; Mizushima T; Jiang G; Netto GJ; Gotoh M; Miyamoto H
Mol Cancer Ther; 2018 Jun; 17(6):1303-1314. PubMed ID: 29592878
[TBL] [Abstract][Full Text] [Related]
13. Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness.
Peng T; Zhou W; Guo F; Wu HS; Wang CY; Wang L; Yang ZY
Sci Rep; 2017 Jul; 7(1):5925. PubMed ID: 28724890
[TBL] [Abstract][Full Text] [Related]
14. ITPR3 facilitates tumor growth, metastasis and stemness by inducing the NF-ĸB/CD44 pathway in urinary bladder carcinoma.
Zhang M; Wang L; Yue Y; Zhang L; Liu T; Jing M; Liang X; Ma M; Xu S; Wang K; Wang X; Fan J
J Exp Clin Cancer Res; 2021 Feb; 40(1):65. PubMed ID: 33573671
[TBL] [Abstract][Full Text] [Related]
15. p21WAF1 mediates the IL-15-induced migration and invasion of human bladder cancer 5637 cells via the ERK1/2/NF-κB/MMP-9 pathway.
Park SL; Kim WJ; Moon SK
Int Immunopharmacol; 2014 Sep; 22(1):59-65. PubMed ID: 24953855
[TBL] [Abstract][Full Text] [Related]
16. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling.
Shi F; Deng Z; Zhou Z; Jiang CY; Zhao RZ; Sun F; Cui D; Bei XY; Yang BY; Sun Q; Wang XJ; Wu Q; Xia SJ; Han BM
J Cell Mol Med; 2019 Oct; 23(10):6578-6594. PubMed ID: 31449345
[TBL] [Abstract][Full Text] [Related]
17. miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing Cylindromatosis expression.
Cui X; Kong C; Zhu Y; Zeng Y; Zhang Z; Liu X; Zhan B; Piao C; Jiang Z
Oncotarget; 2016 Jul; 7(30):48547-48561. PubMed ID: 27391066
[TBL] [Abstract][Full Text] [Related]
18. miR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition.
Yang J; Yuan D; Li J; Zheng S; Wang B
Tumour Biol; 2016 Apr; 37(4):4331-41. PubMed ID: 26494000
[TBL] [Abstract][Full Text] [Related]
19. High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer.
Zhang ZF; Zhang HR; Zhang QY; Lai SY; Feng YZ; Zhou Y; Zheng SR; Shi R; Zhou JY
J Transl Med; 2018 Jan; 16(1):9. PubMed ID: 29351801
[TBL] [Abstract][Full Text] [Related]
20. NCAPG promotes tumorigenesis of bladder cancer through NF-κB signaling pathway.
Tang F; Yu H; Wang X; Shi J; Chen Z; Wang H; Wan Z; Fu Q; Hu X; Zuhaer Y; Liu T; Yang Z; Peng J
Biochem Biophys Res Commun; 2022 Sep; 622():101-107. PubMed ID: 35843088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
